mimiX biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. We will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating Point-Of-Care patient specific biological tissue equivalents for regenerative, personalized and precision medicine.
mimiX biotherapeutics’ technology has already demonstrated – with strong scientific evidence – that it offers tissue engineering strategies to overcome today’s obstacles, including the creation of dense networks of micro vascularization. Our technology is a game-changer for regenerative medicine and diagnostics.
Sound Induced Morphogenesis (SIM) is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves.
This versatile method addresses necessities in the broad field of life sciences, finding application in tissue engineering, regenerative medicine, or pharmaceutical research for drug discovery.
With SIM, mimiX biotherapeutics offers the research community a novel R&D platform to complement and advance the existing biofabrication methodologies. SIM provides prospects to overcome some major limitations of conventional methods towards the creation of physiologically relevant in vitro models and engineered tissue constructs.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.
